Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China
· Delayed Price · Currency is CNY 13.21
+0.11 (0.84%)
Mar 9, 2026, 3:04 PM CST
SHE:002727 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,584 | 7,625 | 13,803 | 18,782 | 22,959 | 19,830 | Upgrade
|
| Market Cap Growth | 2.54% | -44.76% | -26.51% | -18.19% | 15.78% | 50.15% | Upgrade
|
| Enterprise Value | 7,357 | 7,679 | 13,717 | 19,101 | 23,481 | 18,129 | Upgrade
|
| Last Close Price | 13.21 | 12.62 | 22.03 | 29.53 | 35.52 | 30.51 | Upgrade
|
| PE Ratio | 85.58 | 66.80 | 25.12 | 18.60 | 24.91 | 25.10 | Upgrade
|
| Forward PE | 18.48 | 10.17 | 13.00 | 16.59 | 19.48 | 22.86 | Upgrade
|
| PS Ratio | 0.44 | 0.42 | 0.79 | 1.08 | 1.57 | 1.57 | Upgrade
|
| PB Ratio | 1.02 | 1.00 | 1.75 | 2.50 | 3.44 | 3.43 | Upgrade
|
| P/TBV Ratio | 1.48 | 1.44 | 2.33 | 3.20 | 4.52 | 4.37 | Upgrade
|
| P/FCF Ratio | 4.65 | 5.20 | 7.41 | 8.74 | 16.40 | 26.33 | Upgrade
|
| P/OCF Ratio | 3.97 | 4.43 | 6.53 | 7.52 | 12.81 | 19.19 | Upgrade
|
| PEG Ratio | - | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 | Upgrade
|
| EV/Sales Ratio | 0.42 | 0.43 | 0.79 | 1.10 | 1.61 | 1.43 | Upgrade
|
| EV/EBITDA Ratio | 4.68 | 15.58 | 14.16 | 13.34 | 18.30 | 18.51 | Upgrade
|
| EV/EBIT Ratio | 22.00 | 20.04 | 16.25 | 14.50 | 19.81 | 20.15 | Upgrade
|
| EV/FCF Ratio | 4.51 | 5.24 | 7.37 | 8.89 | 16.77 | 24.07 | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.40 | 0.38 | 0.41 | 0.44 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.79 | 1.86 | 1.50 | 1.33 | 1.28 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 1.73 | 2.07 | 1.61 | 1.44 | 2.08 | 0.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.05 | -0.05 | -0.11 | -0.06 | 0.06 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.88 | -0.78 | -0.93 | -0.30 | 0.29 | -3.06 | Upgrade
|
| Net Debt / FCF Ratio | -0.23 | -0.26 | -0.48 | -0.20 | 0.27 | -3.98 | Upgrade
|
| Asset Turnover | 1.06 | 1.08 | 1.06 | 1.14 | 1.23 | 1.46 | Upgrade
|
| Inventory Turnover | 3.13 | 3.13 | 3.26 | 3.43 | 3.38 | 3.89 | Upgrade
|
| Quick Ratio | 0.75 | 0.70 | 0.80 | 0.82 | 0.70 | 1.15 | Upgrade
|
| Current Ratio | 1.31 | 1.27 | 1.37 | 1.38 | 1.31 | 1.90 | Upgrade
|
| Return on Equity (ROE) | 1.09% | 1.42% | 7.28% | 14.27% | 14.73% | 15.21% | Upgrade
|
| Return on Assets (ROA) | 1.27% | 1.43% | 3.21% | 5.40% | 6.26% | 6.50% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.93% | 2.86% | 9.56% | 15.28% | 20.17% | 27.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 4.20% | 8.90% | 14.20% | 14.00% | 15.50% | Upgrade
|
| Earnings Yield | 1.19% | 1.50% | 3.98% | 5.38% | 4.01% | 3.98% | Upgrade
|
| FCF Yield | 21.52% | 19.22% | 13.49% | 11.44% | 6.10% | 3.80% | Upgrade
|
| Dividend Yield | 3.05% | 2.38% | 1.82% | 1.35% | 0.84% | 0.98% | Upgrade
|
| Payout Ratio | 341.07% | 228.27% | 47.40% | 18.97% | 19.63% | 22.15% | Upgrade
|
| Buyback Yield / Dilution | 2.25% | 0.76% | -0.27% | -0.50% | -3.32% | -0.88% | Upgrade
|
| Total Shareholder Return | 5.30% | 3.13% | 1.55% | 0.85% | -2.48% | 0.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.